Filing Details

Accession Number:
0001759655-22-000113
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-08 19:29:22
Reporting Period:
2022-08-05
Accepted Time:
2022-08-08 19:29:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759655 Privia Health Group Inc. PRVA Services-Health Services (8000) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1858396 David Mountcastle Privia Health Group, Inc.
950 N. Glebe Rd., Suite 700
Arlington VA 22203
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2022-08-05 63,694 $2.00 183,086 No 4 M Direct
Common Stock, Par Value $0.01 Per Share Disposition 2022-08-05 30,594 $37.66 152,492 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Purchase) Disposition 2022-08-05 63,694 $0.00 63,694 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,899 2028-08-27 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.45 to $38.07 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transaction reported in this Form 4, 102,074 of the stock options are fully vested and exercisable. 25,519 will vest on October 29, 2022.